SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Discovery Laboratories Release: New Pharmacoeconomic Analysis Shows Lower Rate of Reintubation Observed With SURFAXIN® Treatment May Reduce Hospital Costs Associated with Bronchopulmonary Dysplasia